Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Nyctalopin ELISA Kit (AC3023)
Cat.#: ASET-1612
Specifications
Description Human Nyctalopin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Nyctalopin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.058 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1827 Mouse CRF ELISA Kit (AC3238) Quantitative inquiry ASET-1420 Human ALDH1A1 ELISA Kit (AC2831) Quantitative inquiry ASET-1363 Rat ACTH ELISA Kit (AC2774) Quantitative inquiry ASET-1237 Human NRXN3 ELISA Kit (AC2648) Quantitative inquiry ASET-1879 Mouse TIMP3 ELISA Kit (AC3290) Quantitative inquiry ASET-2354 Human Renalase ELISA Kit (AC3765) Quantitative inquiry ASET-1407 Human BMAL1 ELISA Kit (AC2818) Quantitative inquiry ASET-1794 Mouse alpha Synuclein ELISA Kit (AC3205) Quantitative inquiry ASET-2320 Mouse Semaphorin 3A ELISA Kit (AC3731) Quantitative inquiry ASET-1868 Human CASK ELISA Kit (AC3279) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket